Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.76%297.13M | -13.19%276.09M | 2.50%1.32B | 10.85%325.57M | 13.10%365.85M | -16.76%311.99M | 7.00%318.02M | -1.87%1.29B | -12.67%293.71M | 0.59%323.49M |
| Cost of revenue | 5.94%1.23B | -0.30%1.16B | ||||||||
| Gross profit | -29.35%88.77M | -14.34%125.65M | ||||||||
| Operating expense | -3.62%303.6M | -14.22%275.57M | -2.45%69.02M | 13.28%318.78M | 14.21%362.28M | -13.71%314.99M | 14.41%321.24M | 6.62%70.75M | 132.63%281.42M | -1.74%317.19M |
| Selling and administrative expenses | ---- | ---- | -2.12%69.71M | ---- | ---- | ---- | ---- | 6.35%71.22M | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | -4.40%20.16M | ---- | ---- | ---- | ---- | 21.21%21.08M | ---- | ---- |
| -General and administrative expense | ---- | ---- | -1.17%49.55M | ---- | ---- | ---- | ---- | 1.13%50.13M | ---- | ---- |
| Other operating expenses | -3.62%303.6M | -14.22%275.57M | -49.00%-599K | 13.28%318.78M | 14.21%362.28M | -13.71%314.99M | 14.41%321.24M | ---402K | --281.42M | -1.74%317.19M |
| Total other operating income | ---- | ---- | 29.41%88K | ---- | ---- | ---- | ---- | -88.82%68K | ---- | ---- |
| Operating profit | -115.43%-6.46M | 116.00%515K | -64.02%19.76M | -44.75%6.79M | -43.20%3.58M | -130.68%-3M | -119.58%-3.22M | -31.65%54.9M | -61.08%12.29M | 622.14%6.3M |
| Net non-operating interest income (expenses) | 38.45%-4.07M | 13.33%-4.86M | 0.75%-23.58M | 8.35%-5.29M | -3.98%-6.45M | -5.64%-6.61M | 6.15%-5.61M | -28.99%-23.76M | -14.33%-5.77M | -17.39%-6.21M |
| Non-operating interest income | ---- | ---- | -16.11%380K | ---- | ---- | ---- | ---- | -13.71%453K | ---- | ---- |
| Non-operating interest expense | -38.45%4.07M | -13.33%4.86M | -1.03%23.96M | -8.35%5.29M | 3.98%6.45M | 5.64%6.61M | -6.15%5.61M | 27.81%24.21M | 3.55%5.77M | 17.39%6.21M |
| Net investment income | 195.12%5.26M | 55.77%1.78M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -95.83%1K | 4.65%45K | 5,000.00%102K | 550.00%13K | 22K | 24K | 43K | 103.85%2K | 2K | 0 |
| Special income (charges) | -1,459.52%-3.43M | 111.16%252K | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---27K | ---- | ---- |
| Less:Write off | ---- | ---- | 1,622.67%3.43M | ---- | ---- | ---- | ---- | -109.96%-225K | ---- | ---- |
| Other non-operating income (expenses) | -71.64%407K | 1,271.22%5.62M | -54.19%-9.6M | 27.64%3.35M | 304.97%3.02M | 49.79%1.44M | -79.78%410K | -1.93%-6.23M | 126.81%2.63M | 92.51%745K |
| Income before tax | -24.21%-10.12M | 115.75%1.32M | -142.63%-11.49M | -46.79%4.87M | -80.41%164K | -281.90%-8.15M | -167.09%-8.38M | -50.66%26.96M | -41.43%9.15M | 113.71%837K |
| Income tax | -24.71%329K | -24.53%283K | -77.15%1.4M | -59.86%733K | 15.52%-147K | -77.07%437K | -85.35%375K | -51.46%6.12M | 80.97%1.83M | 23.35%-174K |
| Net income | -21.72%-10.45M | 111.84%1.04M | -161.86%-12.89M | -43.54%4.14M | -69.24%311K | -433.57%-8.59M | -188.16%-8.75M | -50.42%20.84M | -49.88%7.33M | 117.20%1.01M |
| Net income continuous operations | -21.72%-10.45M | 111.84%1.04M | -161.86%-12.89M | -43.54%4.14M | -69.24%311K | -433.57%-8.59M | -188.16%-8.75M | -50.42%20.84M | -49.88%7.33M | 117.20%1.01M |
| Noncontrolling interests | -112.80%-3.74M | 69.71%-805K | -511.98%-8.39M | -195.99%-2.08M | -226.60%-1.89M | -454.57%-1.76M | -447.91%-2.66M | 6.76%2.04M | 443.04%2.17M | 41.34%-579K |
| Net income attributable to the company | 1.73%-6.71M | 130.21%1.84M | -123.94%-4.5M | 20.53%6.22M | 38.49%2.2M | -336.18%-6.83M | -166.51%-6.09M | -53.14%18.8M | -66.17%5.16M | 132.51%1.59M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1.73%-6.71M | 130.21%1.84M | -123.94%-4.5M | 20.53%6.22M | 38.49%2.2M | -336.18%-6.83M | -166.51%-6.09M | -53.14%18.8M | -66.17%5.16M | 132.51%1.59M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 1.84%-0.016 | 130.14%0.0044 | -125.00%-0.01 | 21.14%0.0149 | 39.47%0.0053 | -336.23%-0.0163 | -166.67%-0.0146 | -60.00%0.04 | -69.70%0.0123 | 132.48%0.0038 |
| Diluted earnings per share | 1.84%-0.016 | 130.14%0.0044 | -125.00%-0.01 | 21.14%0.0149 | 39.47%0.0053 | -336.23%-0.0163 | -166.67%-0.0146 | -60.00%0.04 | -66.25%0.0123 | 132.48%0.0038 |
| Dividend per share | 0 | 0 | 50.00%0.015 | 0 | 0 | 50.00%0.015 | 0 | 0.00%0.01 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.